Literature DB >> 3758149

Pharmacokinetics of fluocortolone in man.

U F Legler.   

Abstract

The kinetics of the synthetic corticoid fluocortolone was determined in 9 healthy female volunteers after a single oral dose of 20 mg. The maximal plasma level fluocortolone (Cmax) of 202 +/- 70 ng/ml occurred within 85 +/- 32 min of oral intake after which it declined monoexponentially. Total plasma clearance was 6.48 +/- 2.07 ml/min X kg and the clearance of unbound fluocortolone was 60.38 +/- 26.67 ml/min X kg. Plasma protein binding was 83 to 95%. The volume of distribution at steady-state was 1.01 +/- 0.341/kg for total fluocortolone and 11.21 +/- 3.771/kg for unbound drug. The results of the study characterize the kinetics of unbound fluocortolone for the first time. In addition, the kinetics of total fluocortolone presented here confirm values calculated previously.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758149     DOI: 10.1007/bf00542423

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens.

Authors:  L E Gustavson; U F Legler; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

2.  Errors in interpretation of data from equilibrium dialysis protein binding experiments.

Authors:  H L Behm; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-10

3.  Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.

Authors:  T N Tozer; J G Gambertoglio; D E Furst; D S Avery; N H Holford
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

4.  The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.

Authors:  U Täuber; D Haack; B Nieuweboer; G Kloss; P Vecsei; H Wendt
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-01

Review 5.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

7.  Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

Authors:  F J Frey; B M Frey; L Z Benet
Journal:  Clin Chem       Date:  1979-11       Impact factor: 8.327

8.  [Metabolism of 6 -fluor-16 -methylpregna-1,4-dien-ll ,21-diol-3,20-dion (fluocortolone) in man. Isolation of 6 -hydroxylated metabolites (alkyl-substituted steroids VII)].

Authors:  E Gerhards; B Nieuweboer; G Schulz; H Gibian
Journal:  Acta Endocrinol (Copenh)       Date:  1971-09

9.  Prednisolone clearance at steady state in dogs.

Authors:  F J Frey; B M Frey; A Greither; L Z Benet
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

  9 in total
  2 in total

1.  Lack of impairment of fluocortolone disposition in oral contraceptive users.

Authors:  U F Legler
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Pharmacodynamic modeling of cortisol suppression from fluocortolone.

Authors:  K H Lew; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.